Ling‐Wen Ding
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 6
-
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 6
- Cancer-related gene regulation 6
- Protein Degradation and Inhibitors 5
- Co-authors
- H. Phillip Koeffler (33 shared papers)De‐Chen Lin (20 shared papers)Boon Cher Goh (6 shared papers)Lingzhi Wang (5 shared papers)Xiaoqiang Xiang (4 shared papers)Qiao‐Yang Sun (19 shared papers)Paul C. Ho (2 shared papers)Anand Mayakonda (11 shared papers)
- Journals
- Cancer Research (8 papers)Blood (5 papers)Nature Communications (4 papers)Advanced Materials (4 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Ling‐Wen Ding
72 papers receiving 4.2k citations
Ling‐Wen Ding's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 912
- Molecular Biology 2.5k
- Geriatrics and Gerontology 106
- Oncology 810
- Hematology 271
Countries citing papers authored by Ling‐Wen Ding
This map shows the geographic impact of Ling‐Wen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wen Ding more than expected).
Fields of papers citing papers by Ling‐Wen Ding
This network shows the impact of papers produced by Ling‐Wen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wen Ding. The network helps show where Ling‐Wen Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling‐Wen Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic and molecular characterization of esophageal squamous cell carcinoma Hit paper breakdown → | 2014 | 518 |
| 2 | Resveratrol for cancer therapy: Challenges and future perspectives Hit paper breakdown → | 2021 | 386 |
| 3 | 2014 | 310 | |
| 4 | 2018 | 193 | |
| 5 | 2016 | 180 | |
| 6 | 2015 | 179 | |
| 7 | 2017 | 166 | |
| 8 | 2021 | 100 | |
| 9 | 2023 | 99 | |
| 10 | 2017 | 97 | |
| 11 | 2018 | 90 | |
| 12 | 2021 | 89 | |
| 13 | 2017 | 86 | |
| 14 | 2014 | 78 | |
| 15 | 2022 | 78 | |
| 16 | 2019 | 72 | |
| 17 | 2016 | 71 | |
| 18 | 2013 | 70 | |
| 19 | 2014 | 66 | |
| 20 | 2021 | 65 |
About Ling‐Wen Ding
Ling‐Wen Ding is a scholar working on Cancer Research, Molecular Biology, Hematology, Oncology and Immunology, having authored 77 papers that have together received 4.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), RNA modifications and cancer (7 papers), Ubiquitin and proteasome pathways (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer-related gene regulation (6 papers), MicroRNA in disease regulation (6 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Cancer Research (912 citations), Molecular Biology (2.5k citations), Geriatrics and Gerontology (106 citations), Oncology (810 citations) and Hematology (271 citations). Ling‐Wen Ding has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include H. Phillip Koeffler, De‐Chen Lin, Boon Cher Goh, Lingzhi Wang, Xiaoqiang Xiang, Qiao‐Yang Sun, Paul C. Ho, Anand Mayakonda, Pei Shi Ong and Henry He Yang. Their work appears in journals such as Cancer Research, Blood, Nature Communications, Advanced Materials and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.